Maintaining the primary lymphocyte pools is a challenge for the immune system: it must balance the need to minimize the risk of developing a lymphocyte repertoire that is autoreactive or of ineffective spe cificity with the need to preserve sufficient lymphocyte numbers for adequate immuno logical surveillance. In B cells, these conflicting demands are coordinated by a mutually dependent relationship between the B cell receptor (BCR) and the receptor for B cellactivating factor (BAFFR; also known as BR3 or TNFRSF13C).
BCRmediated selection controls B cell survival based on intrinsic clonal fitness, such that excessively strong or weak BCR signals identify autoreactive or functionally unfit B cell clonotypes, respectively. Negative selec tion against autoreactive BCR specificities begins at the immature B cell differentiation stage in the bone marrow and continues dur ing the transitional B cell stages in the periph ery (FIG. 1a) . In general, the elimination (or negative selection) of B cells at the immature stage in the bone marrow occurs following high avidity BCR interactions with anti gen, whereas B cells that undergo sustained BCR-antigen interactions of intermediate avidity persist to the transitional stages in the periphery, but die before they mature [1] [2] [3] .
The occurrence of positive selection among B cells has only been recognized more recently, but it is thought to require persistent subthreshold BCR signalling in both devel oping and mature B cells [4] [5] [6] [7] . Indeed, B cell differentiation requires BCR signalling from the late proB cell stage onwards 5 , and mature B cells require continuous signals (known as tonic signals) through the BCR to survive 6 . Cells that survive negative selection and meet the BCR signalling requirements for positive selection can mature and persist as primary B cell subsets.
Together, these observations led to the idea that BCR signal strength is the sole determinant of B cell survival at the imma ture and transitional stage checkpoints, as well as for the mature follicular and marginal zone B cells that comprise the preimmune primary B cell repertoire. However, it is now clear that signals through BAFFR have an equally important role in determining the fate of developing and mature B cells (FIG. 1b) . In contrast to the cellintrinsic measure of B cell fitness provided by BCR signals, BAFFRmediated survival is linked to the cellextrinsic parameter of primary B cell population size, such that the amount of available BAFF (also known as BLyS or TNFSF13B) is a measure of unfilled 'space' in the B cell compartment. This is shown by the observations that steadystate numbers of quiescent primary B cells are increased when BAFF levels are increased 8, 9 and, con versely, that B cell numbers are decreased when BAFFR signals are compromised 10 or when BAFF is neutralized in vivo 9, 11, 12 . BAFFR is first expressed by B cells dur ing the transitional stages and its expression level increases with further differentiation, such that the highest levels of expression are found in follicular and marginal zone B cells [13] [14] [15] . In keeping with this expres sion pattern, in vivo labelling studies 10, 15, 16 showed that BAFFmediated signals through BAFFR control steadystate B cell num bers by regulating both the proportion of transitional B cells that complete their differentiation and the lifespan of mature primary B cells 10, 15, 16 . Whether a B cell can acquire BAFF and transduce BAFFR sig nals effectively determines the probability of its survival. So, the set point for the size of the primary B cell pool is reached when available BAFF levels become limiting and B cells must compete with one another for BAFF. This competitive relationship was initially revealed through studies using mixed chimeras, in which B cells derived from BAFFRdeficient haematopoietic stem cells had an intrinsic disadvantage in terms of maturation and survival when in competition with BAFFRsufficient B cells 10 . Interestingly, these observations were remi niscent of prior studies showing that BCR specificity and signal strength influence the competitive fitness of B cells [17] [18] [19] , which foreshadowed a connection between the BCR and BAFFR in determining the fate of emerging and mature B cells.
BAFFR and BCR signals are integrated Importantly, B cells that fail to signal through either the BCR or BAFFR die, indicating that both receptors are necessary but neither is sufficient for B cell survival. For example, conditional deletion of the BCR or its immediate downstream signal ling components leads to the death of most B cells 6, 7, 20 [22] [23] [24] . Furthermore, with increased BCR signal strength, the effectiveness of such rescue by excess BAFF decreased 23 . So, the range of BCR signal strength that is com patible with B cell survival at the transitional stage checkpoint varies depending on the level of available BAFF (FIG. 1b) . B cells that undergo deletion (negative selection) at the immature bone marrow stage, which do not yet express BAFFR, cannot be rescued by excess BAFF 23 . These features of B cell physiology provide a model to study the molecular mechanisms that determine cell fate decisions in response to potentially conflicting demands: the need for appropriate clonotypic fitness, measured in terms of BCR signal strength, and the need for a sufficiently large B cell population, linked to the availability of BAFF. It is possible that there is a direct regulatory relationship between the BCR and BAFFR, but although BCR signals can modulate BAFFR expres sion levels 25 , they might not be required for BAFFR expression per se. Alternatively, the survival signals directly mediated by each receptor might be additive, but this mecha nism does not explain how excess BAFF can rescue B cells that would otherwise be deleted on the basis of high BCR signal strength or why signalling through one receptor can not overcome blocks in the other receptor signalling pathway.
Recent findings 13 indicate that crosstalk between the downstream mediators of BCR and BAFFR signals can explain the mutual dependence and crossregulation of these receptors, as well as the increasing resistance of B cells to BCRmediated death as the cells mature. In this model, the signals from one receptor (the BCR) generate a ratelimiting substrate that is required for transcriptional regulatory systems that are activated by the other receptor (BAFFR). Such crosstalk might be a general model for how cell fate is determined by balancing intrinsic measures of functional fitness against extrinsic measures of systemic integrity. BCR signals sustain a BAFFR substrate The nuclear factorκB (NFκB) system of transcriptional regulatory proteins is crucial for many downstream events that follow BCR ligation 26 . This family of tran scription factors can be activated by two separate but overlapping pathways 27 , each of which can generate both negative and positive transcriptional regulators. The canonical (or classical) pathway involves the phosphorylation and degradation of the inhibitor of NFκBα (IκBα) and the subsequent pairing of NFκB1 (also known as p50) with one of several partners to form transcriptionally active heterodim ers that then translocate to the nucleus to mediate gene transcription. The non canonical (or alternative) pathway instead involves NFκBinducing kinase (NIK) initiated processing of p100 to generate NFκB2 (also known as p52), leading to the formation and nuclear translocation of transcriptionally active NFκB2-ReLB heterodimers [27] [28] [29] . Both the canonical and noncanonical NFκB pathways are neces sary for B cell survival; mice that lack vari ous components of either pathway have similar phenotypes to mice with BCR or BAFFR signalling mutations. For example, deficiencies of components of the canonical NFκB1 pathway lead to failures of primary B cell differentiation 20 . Indeed, BCL10 (B cell lymphoma 10) deficiency -which prevents NFκB1 activation by BCR signal ling -results in a marked decrease in the number of mature follicular and marginal zone B cells 30 despite normal bone marrow and transitional B cell compartments 30, 31 , a phenotype that is similar to that observed for mice with a mutation in the gene encod ing BAFFR 10, 16 . Mutations or deficiencies of components of the noncanonical NFκB2 pathway also result in phenotypes that are reminiscent of BAFF and/or BAFFR defi ciency 32, 33 . Together, these findings indicate that, analogous to studies directly investi gating the BCR or BAFFR, a combination of both NFκB pathways is necessary for the full function of either receptor [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] . Because of their central roles in B cell biology, the signalling cascades down stream of both the BCR and BAFFR have been investigated in great detail. BCR signals are initiated by SRC family kinases, which phosphorylate BCRassociated immunoreceptor tyrosinebased activation motifs (ITAMs) 44, 45 . Subsequent phospho rylation of SYK (spleen tyrosine kinase) initiates signal propagation through mul tiple pathways, including activation of the phosphoinositide 3kinase (pI3K) pathway and initiation of the canonical NFκB1 pathway. In contrast to the ITAMinitiated signalling of the BCR, the proximal events in BAFFR signalling -as for most tumour necrosis factor (TNF) family members -involve TNF receptorassociated fac tors (TRAFs). Activated BAFFR interacts with TRAF3 46 , preventing TRAF2-TRAF3 interactions that would otherwise lead to NIK degradation 47 , and thereby allows p100 processing 39 . Additional analyses in which various downstream components of the BAFFR signalling pathway were geneti cally removed or replaced [41] [42] [43] showed that although BAFFR ligation mainly results in activation of the noncanonical NFκB2 pathway, the canonical NFκB1 pathway can also influence BAFFR signalling and B cell survival 39, 43, 48 . It now seems that molecules gener ated by BCR signals are directly involved in the BAFFR signalling cascade, thereby mediating the interdependence and cross modulation of these two receptor signal ling pathways (FIG. 2) . BAFFR signalling mainly activates the noncanonical NFκB2 pathway 33, 49 , and in the absence of other inputs, BAFFR signalling rapidly depletes the amount of available p100 substrate in this pathway 13 . By contrast, although BCR signalling does not itself lead to activation of the noncanonical NFκB2 pathway, p100 is a positively regulated downstream target of BCRinduced gene transcription 48, 50 . So, BCR signals generate p100 but do not promote processing to NFκB2, whereas BAFFR signals result in the processing of p100 but quickly exhaust p100 stores. Accordingly, signalling through both the BCR and BAFFR is required for the sus tained production and nuclear translocation of NFκB2-ReLB heterodimers and the subsequent expression of antiapoptotic genes to allow continued B cell survival. These findings support a model whereby BCR signalling is itself insufficient to ensure B cell viability but enables the sustained delivery of BAFFRmediated survival sig nals by replenishing p100 levels.
This model of receptor crosstalk provides a mechanism for several previously unex plained observations. First, it clarifies why continuous signalling through both BAFFR and the BCR is required for transitional and mature B cell survival. Second, it predicts a stoichiometric relationship between three parameters -the level of BAFF, BCR signal strength and cellular BAFFR density -in determining the threshold for transitional B cell selection and persistence in the pri mary B cell repertoire. This prediction is supported by previous findings showing that the stringency of transitional B cell selection depends on the combination of these three parameters [22] [23] [24] . Finally, the model proposes that acquiring the ability to sustain BCR and BAFFR signalling crosstalk might be a fundamental developmental switch that allows homeostatic demands to modulate the outcome of BCRmediated cell fate decisions. Indeed, immature B cells undergoing negative selection in the bone marrow cannot be rescued by BAFF, pre sumably because of their lack of BAFFR expression. At the transitional B cell stages, the levels of BAFFR expression [13] [14] [15] and the ability of BCR signals to sustain p100 pro duction 13 both increase. This combination of increasing BAFFR signalling capacity and changing BCR signalling proper ties 13, 50, 51 probably underlies the increasing propensity for BAFFmediated survival and decreasing susceptibility to BCRdriven negative selection that are observed during this developmental stage.
Despite these insights into how selec tive and homeostatic processes are inte grated in B cell development, additional questions remain. First, the extent of the BCRmediated signalling cascades that mediate BAFFR crosstalk remains unclear. pharmacological inhibition of the canonical NFκB1 pathway blocks p100 generation 13 , which indicates that this part of the BCR signalling pathway has a role in replenishing p100. However, more complex relationships have been reported and will probably be revealed by further investigation. For example, BAFFR signal ling can itself result in transient NFκB1 activation 13, 39, 48 , which brings into question whether the canonical NFκB1 pathway by itself is sufficient for sustained p100 gen eration and indicates that BCR signalling through pathways other than the NFκB1 pathway might be involved in the produc tion of p100. Furthermore, constitutively active canonical NFκB1 alone can increase B cell numbers in BAFFdeficient mice 43 . Although this indicates that B cell survival can be extended independently of BAFFR signalling in some circumstances, a BAFF sufficient background further increased B cell numbers in the presence of consti tutively active NFκB1, which indicates that the BAFFR and NFκB1 signalling pathways are largely nonredundant. In addition, recent findings indicate that the concomitant generation of other NFκB components, such as ReL (also known as cReL), by BCR signalling could have important roles in determining the Nature Reviews | Immunology 
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Nucleus outcome of signalling crosstalk 50 . Similarly, additional downstream BCR signalling ele ments, such as pI3K, could participate in these crossmodulating activities given their known roles in mediating the differentiation of transitional B cells 52 . In addition to the BCR and BAFFR, the sets of receptors that are involved in such signalling crosstalk might change according to the differentiation stage or type of B cell. Also, some receptors might not require cross talk for full function, making them particu larly potent mediators of B cell survival. For example, CD40 ligation induces both the production and processing of p100 (REFS 13, 53) , perhaps freeing activated B cells from the need for continued BCR signalling.
A remaining conceptual issue is why both low and high BCR signal strength would lead to B cell death under conditions of lim iting BAFFR signals. The stoichiometry and nuclear shuttling of NFκB components are complex 54, 55 , which raises the possibility that their ratios -rather than absolute amounts -might be important in determining the end result. For example, if BCRmediated production of p100 exceeds BAFFRinduced p100 processing, then excess p100 could sequester ReLB or block the action of ReLA, thereby decreasing the levels of functional NFκB heterodimers. Consistent with these general possibilities, mutations in p100 that prevent its processing lead to a super repressor phenotype in which B cell devel opment is blocked at the transitional stages 56 . Also, increased levels of nuclear p100 are observed after strong BCR signalling 13 .
Concluding remarks
It is tempting to speculate that signalling crosstalk -as described here between the BCR and BAFFR -might be a gen eral mechanism by which the degree of intrinsic functional competence required for cell survival can be modulated by the need to maintain systemic homeostasis. This model proposes that signals induced by a lineagespecific functional molecule (for example, the BCR) will provide limit ing components to a survival pathway (for example, the BAFFR pathway), the signal ling intensity of which is proportional to 'space' in the relevant biological niche. In addition to providing a means to integrate conflicting demands in cell fate decisions, the potential to 'tune' levels of acceptable signalling makes this model an attractive concept in lymphocyte biology, albeit with different players in different lymphocyte lineages or subsets. For example, some T cell subsets rely on both the T cell receptor . These include the phosphoinositide 3-kinase (PI3K) pathway, which culminates in the activation of AKT1 and nuclear factor of activated T cells (NFAT), and the activation of Bruton's tyrosine kinase (BTK), which has multiple downstream effects. Among these effects are the induction of phospholipase Cγ2 (PLCγ2) activity, which mediates hydrolysis of phosphatidyl inositol-4,5-bisphosphate (PtdIns(4,5)P 2 ) to produce inositol-1,4,5-trisphosphate (InsP 3 ) and diacylglycerol (DAG), and the activation of protein kinase Cβ (PKCβ), which in turn leads to activation of the canonical nuclear factor-κB1 (NF-κB1; also known as p50) pathway through the BCL-10-MALT1-CARMA1 complex. These mediators have multiple downstream effects, including the upregulation of p100 transcription but not p100 processing. By contrast, the B cell-activating factor receptor (BAFFR) preferentially activates the non-canonical NF-κB2 (also known as p52) pathway by inhibiting interactions between tumour necrosis factor receptor-associated factor 2 (TRAF2) and TRAF3 that otherwise would mediate the degradation of NF-κB-inducing kinase (NIK). The resulting NIK accumulation leads to increased processing of p100 and the generation of NF-κB2-ReLB heterodimers, which translocate to the nucleus where they upregulate the transcription of anti-apoptotic genes. However, BAFFR signals do not generate additional p100 and they can rapidly exhaust cellular stores of p100. so, only continued signalling through both receptors yields sustained anti-apoptotic gene expression and supports B cell survival. BCL-10, B cell lymphoma 10; BLNK, B cell linker; CARMA1, also known as CARD11 (caspase recruitment domaincontaining protein 11); GRB2, growth factor receptor-bound protein 2; IKK, inhibitor of NF-κB kinase; MALT1, mucosa-associated lymphoid tissue lymphoma translocation gene 1; MCL1, myeloid cell leukaemia sequence 1. and interleukin7 or interleukin15 sig nals for survival [57] [58] [59] [60] [61] [62] ; as the downstream components of these pathways are well characterized, this system would allow the possibility of signalling crosstalk to be investigated further. 
